FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202078558> ?p ?o ?g. }

• W3202078558 endingPage "229" @default.
• W3202078558 startingPage "222" @default.
• W3202078558 abstract "Long-term survival after lung transplantation is limited by chronic allograft dysfunction. The aim of this study was to investigate the effect of locally augmented immunosuppression with liposomal cyclosporine A for inhalation (L-CsA-i) for the prevention of bronchiolitis obliterans syndrome (BOS). In a randomized, double-blind, placebo-controlled, multi-center Phase 3 study, 180 LT recipients in BOS grade 0 were planned to receive L-CsA-i or placebo in addition to triple-drug immunosuppression. L-CsA-i was administered twice daily via an Investigational eFlow nebulizer to recipients of single (SLT) and bilateral lung transplants (BLT) within 6–32 weeks posttransplant, and continued for 2 years. The primary endpoint was BOS-free survival. 130 patients were enrolled before the study was prematurely terminated for business reasons. Despite a 2-year actuarial difference in BOS-free survival of 14.1% in favor of L-CsA-i in the overall study population, the primary endpoint was not met (p = .243). The pre-defined per protocol analysis of SLT recipients (n = 24) resulted in a treatment difference of 58.2% (p = .053). No difference was observed in the BLT (n = 48) subpopulation (p = .973). L-CsA-i inhalation was well tolerated. Although this study failed to meet its primary endpoint, the results warrant additional investigation of L-CsA-i in lung transplant recipients." @default.
• W3202078558 created "2021-10-11" @default.
• W3202078558 creator A5001772456 @default.
• W3202078558 creator A5004605323 @default.
• W3202078558 creator A5012574601 @default.
• W3202078558 creator A5018716156 @default.
• W3202078558 creator A5028247097 @default.
• W3202078558 creator A5040375770 @default.
• W3202078558 creator A5040377013 @default.
• W3202078558 creator A5042806096 @default.
• W3202078558 creator A5053293174 @default.
• W3202078558 creator A5057794238 @default.
• W3202078558 creator A5074307674 @default.
• W3202078558 creator A5078455402 @default.
• W3202078558 creator A5082032036 @default.
• W3202078558 creator A5084202983 @default.
• W3202078558 creator A5086976813 @default.
• W3202078558 creator A5088824087 @default.
• W3202078558 date "2022-01-01" @default.
• W3202078558 modified "2023-10-18" @default.
• W3202078558 title "A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation" @default.
• W3202078558 cites W1144699317 @default.
• W3202078558 cites W2007321108 @default.
• W3202078558 cites W2040116689 @default.
• W3202078558 cites W2042154117 @default.
• W3202078558 cites W2049178673 @default.
• W3202078558 cites W2058211676 @default.
• W3202078558 cites W2089422744 @default.
• W3202078558 cites W2108592134 @default.
• W3202078558 cites W2115591184 @default.
• W3202078558 cites W2125078269 @default.
• W3202078558 cites W2165360077 @default.
• W3202078558 cites W2313383367 @default.
• W3202078558 cites W2395414551 @default.
• W3202078558 cites W2559553097 @default.
• W3202078558 cites W2607396025 @default.
• W3202078558 cites W2892500428 @default.
• W3202078558 doi "https://doi.org/10.1111/ajt.16858" @default.
• W3202078558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34587371" @default.
• W3202078558 hasPublicationYear "2022" @default.
• W3202078558 type Work @default.
• W3202078558 sameAs 3202078558 @default.
• W3202078558 citedByCount "11" @default.
• W3202078558 countsByYear W32020785582022 @default.
• W3202078558 countsByYear W32020785582023 @default.
• W3202078558 crossrefType "journal-article" @default.
• W3202078558 hasAuthorship W3202078558A5001772456 @default.
• W3202078558 hasAuthorship W3202078558A5004605323 @default.
• W3202078558 hasAuthorship W3202078558A5012574601 @default.
• W3202078558 hasAuthorship W3202078558A5018716156 @default.
• W3202078558 hasAuthorship W3202078558A5028247097 @default.
• W3202078558 hasAuthorship W3202078558A5040375770 @default.
• W3202078558 hasAuthorship W3202078558A5040377013 @default.
• W3202078558 hasAuthorship W3202078558A5042806096 @default.
• W3202078558 hasAuthorship W3202078558A5053293174 @default.
• W3202078558 hasAuthorship W3202078558A5057794238 @default.
• W3202078558 hasAuthorship W3202078558A5074307674 @default.
• W3202078558 hasAuthorship W3202078558A5078455402 @default.
• W3202078558 hasAuthorship W3202078558A5082032036 @default.
• W3202078558 hasAuthorship W3202078558A5084202983 @default.
• W3202078558 hasAuthorship W3202078558A5086976813 @default.
• W3202078558 hasAuthorship W3202078558A5088824087 @default.
• W3202078558 hasBestOaLocation W32020785582 @default.
• W3202078558 hasConcept C126322002 @default.
• W3202078558 hasConcept C141071460 @default.
• W3202078558 hasConcept C142724271 @default.
• W3202078558 hasConcept C168563851 @default.
• W3202078558 hasConcept C203092338 @default.
• W3202078558 hasConcept C204787440 @default.
• W3202078558 hasConcept C27081682 @default.
• W3202078558 hasConcept C2776739411 @default.
• W3202078558 hasConcept C2777714996 @default.
• W3202078558 hasConcept C2780252810 @default.
• W3202078558 hasConcept C2781448352 @default.
• W3202078558 hasConcept C2908647359 @default.
• W3202078558 hasConcept C2911091166 @default.
• W3202078558 hasConcept C71924100 @default.
• W3202078558 hasConcept C99454951 @default.
• W3202078558 hasConceptScore W3202078558C126322002 @default.
• W3202078558 hasConceptScore W3202078558C141071460 @default.
• W3202078558 hasConceptScore W3202078558C142724271 @default.
• W3202078558 hasConceptScore W3202078558C168563851 @default.
• W3202078558 hasConceptScore W3202078558C203092338 @default.
• W3202078558 hasConceptScore W3202078558C204787440 @default.
• W3202078558 hasConceptScore W3202078558C27081682 @default.
• W3202078558 hasConceptScore W3202078558C2776739411 @default.
• W3202078558 hasConceptScore W3202078558C2777714996 @default.
• W3202078558 hasConceptScore W3202078558C2780252810 @default.
• W3202078558 hasConceptScore W3202078558C2781448352 @default.
• W3202078558 hasConceptScore W3202078558C2908647359 @default.
• W3202078558 hasConceptScore W3202078558C2911091166 @default.
• W3202078558 hasConceptScore W3202078558C71924100 @default.
• W3202078558 hasConceptScore W3202078558C99454951 @default.
• W3202078558 hasIssue "1" @default.
• W3202078558 hasLocation W32020785581 @default.
• W3202078558 hasLocation W32020785582 @default.
• W3202078558 hasLocation W32020785583 @default.
• W3202078558 hasLocation W32020785584 @default.

• next